Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Circulation|April 6, 1999
Diagnostic marker cooperative study for the diagnosis of myocardial infarctionJ Zimmerman, R Fromm, D Meyer, et al.
Clinical Cardiology|July 11, 2001
A double-blind, multicentered study comparing the accuracy of diagnostic markers to predict short- and long-term clinical events and their utility in patients presenting with chest painR Fromm, D Meyer, J Zimmerman, et al.
Journal of the American College of Cardiology|February 1, 1997
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE InvestigatorsP Vantrimpont, J L Rouleau, C C Wun, et al.
The American Journal of Cardiology|November 1, 1995
Physical working capacity after acute myocardial infarction in patients with low ejection fraction and effect of captoprilL H Hartley, G Flaker, L Basta, et al.
American Heart Journal|March 20, 1998
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular EnlargementW D Hager, B R Davis, A Riba, et al.
Medical Care|August 1, 1994
A method of developing and weighting explicit process of care criteria for quality assessmentC M Ashton, D H Kuykendall, M L Johnson, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement InvestigatorsG A Lamas, G C Flaker, G Mitchell, et al.
The New England Journal of Medicine|January 23, 1997
Ventricular dysfunction and the risk of stroke after myocardial infarctionE Loh, M S Sutton, C C Wun, et al.
The New England Journal of Medicine|October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsF M Sacks, M A Pfeffer, L A Moye, et al.
Pageof 2